Showing results (471-480 of 581) with videos related to
Sort By:
Pageof 59
Transplantation|May 16, 1998
Association between interleukin-4-producing T lymphocyte frequencies and reduced risk of graft-versus-host diseaseN Imami, P A Brookes, G Lombardi, et al.In Vivo (Athens, Greece)|September 1, 1988
High dose chemotherapy with autologous bone marrow rescue in small cell lung cancerC Wilson, D Pickering, S Stewart, et al.International Journal of Cancer|January 15, 1987
Establishment and characterization of three new malignant lymphoid cell linesK H Th'ng, G Garewal, L Kearney, et al.Bone Marrow Transplantation|October 19, 2001
Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusionsK Cwynarski, R Goulding, C Pocock, et al.AJNR. American Journal of Neuroradiology|August 1, 1996
Assessment of brain changes with registered MR before and after bone marrow transplantation for chronic myeloid leukemiaH R Jäger, E J Williams, D G Savage, et al.Blood|November 15, 1996
Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell lineK Nason-Burchenal, D Gandini, M Botto, et al.Blood|November 15, 1993
Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation GroupW Arcese, J M Goldman, E D'Arcangelo, et al.Leukemia|February 1, 1995
Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrowF van Rhee, D I Marks, F Lin, et al.Bone Marrow Transplantation|January 1, 1997
Paranasal sinusitis following allogeneic bone marrow transplantD G Savage, P Taylor, J Blackwell, et al.Cancer Research|July 26, 2000
Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21)S Kulkarni, C Heath, S Parker, et al.Pageof 59